Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8673)
All Articles published online
|
Publishing Process of This Article
|
May 18, 2015 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Waghray A, Murali AR, Menon KN. Hepatocellular carcinoma: From diagnosis to treatment. World J Hepatol 2015; 7(8): 1020-1029 [PMID: 26052391 DOI: 10.4254/wjh.v7.i8.1020] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i8/1020.htm |
| Number | Citing Articles |
| 1 |
Ke Li, Baiyong Shen, Xi Cheng, Ding Ma, Xiaoqian Jing, Xinyu Liu, Weiping Yang, Chenghong Peng, Weihua Qiu. Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma. Cancer Research 2016; 76(14): 4205 doi: 10.1158/0008-5472.CAN-15-3385
|
| 2 |
Yubin Li, Runzhe Chen, Jian Yang, Shaowei Mo, Kelly Quek, Chung H. Kok, Xiang-Dong Cheng, Saisai Tian, Weidong Zhang, Jiang-Jiang Qin. Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Pathways Associated With Clinical Outcome in Hepatocellular Carcinoma. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00814
|
| 3 |
Raghda Saad Zaghloul Taleb, Pacint Moez, Doreen Younan, Martin Eisenacher, Matthias Tenbusch, Barbara Sitek, Thilo Bracht. Quantitative proteome analysis of plasma microparticles for the characterization of HCV‐induced hepatic cirrhosis and hepatocellular carcinoma. PROTEOMICS – Clinical Applications 2017; 11(11-12) doi: 10.1002/prca.201700014
|
| 4 |
Aleksandar Bogdanovic, Predrag Bulajic, Marinko Zuvela, Nemanja Bidzic, Marko Zivanovic, Danijel Galun. Impact of diseased liver parenchyma on perioperative outcome among patients with hepatocellular carcinoma undergoing hepatectomy: Experience from a developing country. Surgical Oncology 2020; 35: 236 doi: 10.1016/j.suronc.2020.09.009
|
| 5 |
Shiyang Zhai, Huimin Zhang, Rui Chen, Jiangxia Wu, Daiqiao Ai, Shunming Tao, Yike Cai, Ji-Quan Zhang, Ling Wang. Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma. European Journal of Medicinal Chemistry 2021; 225: 113824 doi: 10.1016/j.ejmech.2021.113824
|
| 6 |
Nahla F. Osman, Mohamed A. Helwa, Mahmoud A. El Tahawy, Eman Abdelsameea, Hanan Bedir. TRAIL-R1 polymorphisms predict the risk of development of hepatocellular carcinoma in Egyptian patients with chronic hepatitis C. Egyptian Liver Journal 2016; 6(2): 30 doi: 10.1097/01.ELX.0000514040.77134.c0
|
| 7 |
Jennifer N. Harmon, Foad Kabinejadian, Joseph L. Bull. Ultrasound-Guided Gas Embolization Using a Single Linear Array Transducer. 2019 IEEE International Ultrasonics Symposium (IUS) 2019; : 1193 doi: 10.1109/ULTSYM.2019.8926148
|
| 8 |
Erick Thokerunga, Fangfang Huang, Christian Cedric Bongolo, Simon Peter Rugera, Gilbert Akankwatsa, Jian-Cheng Tu. FKBP11 upregulation promotes proliferation and migration in hepatocellular carcinoma. Cancer Biomarkers 2023; 37(2): 109 doi: 10.3233/CBM-220440
|
| 9 |
Jiangsheng Huang, Jixiong Hu, Xianling Liu, Zhongkun Zuo, Tenglong Tang. Atlas of Anatomic Hepatic Resection for Hepatocellular Carcinoma. 2019; : 7 doi: 10.1007/978-981-13-0668-6_2
|
| 10 |
Jennifer N. Harmon, Foad Kabinejadian, Robinson Seda, Mario L. Fabiilli, Sibu P. Kuruvilla, Joan M. Greve, Brian J. Fowlkes, Joseph L. Bull. Gas Embolization in a Rodent Model of Hepatocellular Carcinoma Using Acoustic Droplet Vaporization. 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 2018; : 6048 doi: 10.1109/EMBC.2018.8513518
|
| 11 |
Chao An, Zhigang Cheng, Xiaoling Yu, Zhiyu Han, Fangyi Liu, Xin Li, Song song Wu, Jie Yu, Ping Liang. Ultrasound-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: oncologic outcomes and advanced assistive technology. International Journal of Hyperthermia 2020; 37(1): 89 doi: 10.1080/02656736.2019.1711203
|
| 12 |
Zaki H Hakami. Biomarker discovery and validation for gastrointestinal tumors: A comprehensive review of colorectal, gastric, and liver cancers. Pathology - Research and Practice 2024; 255: 155216 doi: 10.1016/j.prp.2024.155216
|
| 13 |
|
| 14 |
Zhiwu Jiang, Xiaofeng Jiang, Suimin Chen, Yunxin Lai, Xinru Wei, Baiheng Li, Simiao Lin, Suna Wang, Qiting Wu, Qiubin Liang, Qifa Liu, Muyun Peng, Fenglei Yu, Jianyu Weng, Xin Du, Duanqing Pei, Pentao Liu, Yao Yao, Ping Xue, Peng Li. Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma. Frontiers in Immunology 2017; 7 doi: 10.3389/fimmu.2016.00690
|
| 15 |
Mohammed Elshamy, Federico Aucejo, K V Narayanan Menon, Bijan Eghtesad. Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria. World Journal of Hepatology 2016; 8(21): 874-880 doi: 10.4254/wjh.v8.i21.874
|
| 16 |
Yichen Liu, Qiong Zhao, Tao Xi, Lufeng Zheng, Xiaoman Li. MicroRNA-9 as a paradoxical but critical regulator of cancer metastasis: Implications in personalized medicine. Genes & Diseases 2021; 8(6): 759 doi: 10.1016/j.gendis.2020.10.005
|
| 17 |
Yubo Tang, Jie Chen, Jiaqi Li, Yifan Zheng, Xiuxiu Zhong, Shuai Huang, Bin Chen, Baogang Peng, Xuenong Zou, Xiao Chen. Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27kip1 signaling pathway. Phytomedicine 2021; 86: 153563 doi: 10.1016/j.phymed.2021.153563
|
| 18 |
Nicholas J. Monteleone, Carol S. Lutz. miR-708-5p: a microRNA with emerging roles in cancer. Oncotarget 2017; 8(41): 71292 doi: 10.18632/oncotarget.19772
|
| 19 |
Youcai Li, Jun Zhang, Jiamei Gu, Kongzhen Hu, Shun Huang, Peter S. Conti, Hubing Wu, Kai Chen. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma. Molecular Imaging and Biology 2020; 22(1): 134 doi: 10.1007/s11307-019-01356-z
|
| 20 |
Qiao Jin, Hao Hu, Siqi Yan, Long Jin, Yuliang Pan, Xiangjun Li, Yayi Peng, Peiguo Cao. lncRNA MIR22HG-Derived miR-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.572585
|
| 21 |
Chetan K. Rane, Audrey Minden. P21 activated kinase signaling in cancer. Seminars in Cancer Biology 2019; 54: 40 doi: 10.1016/j.semcancer.2018.01.006
|
| 22 |
Chen-ying Lu, Jian-song Ji, Xiu-liang Zhu, Pei-feng Tang, Qian Zhang, Nan-nan Zhang, Zu-hua Wang, Xiao-Juan Wang, Wei-qian Chen, Jing-bo Hu, Yong-Zhong Du, Ri-Sheng Yu. T2-Weighted Magnetic Resonance Imaging of Hepatic Tumor Guided by SPIO-Loaded Nanostructured Lipid Carriers and Ferritin Reporter Genes. ACS Applied Materials & Interfaces 2017; 9(41): 35548 doi: 10.1021/acsami.7b09879
|
| 23 |
Monika Gjorgjieva, Julien Calderaro, Laure Monteillet, Marine Silva, Margaux Raffin, Marie Brevet, Caroline Romestaing, Damien Roussel, Jessica Zucman-Rossi, Gilles Mithieux, Fabienne Rajas. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia. Journal of Hepatology 2018; 69(5): 1074 doi: 10.1016/j.jhep.2018.07.017
|
| 24 |
Mayadah M. Abdelsalam, Nageh El-Mahdy, Sabry Abou-Saif. Direct-acting antivirals sofosbuvir and daclatasvir attenuate carbon tetrachloride-induced liver fibrosis in mice. Liver Research 2023; 7(1): 71 doi: 10.1016/j.livres.2023.02.001
|
| 25 |
Yunpeng Hua, Fei Ji, Shunjun Fu, Shunli Shen, Shaoqiang Li, Lijian Liang, Baogan Peng. The preoperative neutrophil-to-lymphocyte ratio predicts the outcomes of patients with hepatocellular carcinoma and cirrhosis after hepatectomy ⁎. Oncology and Translational Medicine 2015; 1(6): 249 doi: 10.1007/s10330-015-0117-5
|
| 26 |
Behzad Yeganeh, Adel Rezaei Moghadam, Javad Alizadeh, Emilia Wiechec, Seyed Moayed Alavian, Mohammad Hashemi, Bita Geramizadeh, Afshin Samali, Kamran Bagheri Lankarani, Martin Post, Payam Peymani, Kevin M Coombs, Saeid Ghavami. Hepatitis B and C virus-induced hepatitis: Apoptosis, autophagy, and unfolded protein response. World Journal of Gastroenterology 2015; 21(47): 13225-13239 doi: 10.3748/wjg.v21.i47.13225
|
| 27 |
Ping Luo, Sanyun Wu, Yalan Yu, Xinliang Ming, Shuo Li, Xuelan Zuo, Jiancheng Tu. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage. Pathology & Oncology Research 2020; 26(2): 599 doi: 10.1007/s12253-019-00585-5
|
| 28 |
Xuefang Liu, Xinliang Ming, Wei Jing, Ping Luo, Nandi Li, Man Zhu, Mingxia Yu, Chunzi Liang, Jiancheng Tu. Long non-coding RNA XIST predicts worse prognosis in digestive system tumors: a systemic review and meta-analysis. Bioscience Reports 2018; 38(3) doi: 10.1042/BSR20180169
|
| 29 |
Lindsay Sobotka, Alice Hinton, Lanla Conteh. Women receive more inpatient resections and ablations for hepatocellular carcinoma than men. World Journal of Hepatology 2017; 9(36): 1346-1351 doi: 10.4254/wjh.v9.i36.1346
|
| 30 |
Eva Lieto, Gennaro Galizia, Francesca Cardella, Andrea Mabilia, Nicoletta Basile, Paolo Castellano, Michele Orditura, Annamaria Auricchio. Indocyanine Green Fluorescence Imaging-Guided Surgery in Primary and Metastatic Liver Tumors. Surgical Innovation 2018; 25(1): 62 doi: 10.1177/1553350617751451
|
| 31 |
Vadanasundari Vedarethinam, Karthik Dhanaraj, Soundharrajan Ilavenil, Mariadhas Arasu, Ki Choi, Naif Al-Dhabi, Srigopalram Srisesharam, Kyung Lee, Da Kim, Tamilvenvendan Dhanapal, Ravikumar Sivanesan, Han Choi, Young Kim. Antitumor Effect of the Mannich Base(1,3-bis-((3-Hydroxynaphthalen-2-yl)phenylmethyl)urea) on Hepatocellular Carcinoma. Molecules 2016; 21(5): 632 doi: 10.3390/molecules21050632
|
| 32 |
Ana Paula Pagano, Juliana Maria Faccioli Sicchieri, Clara Romanholi Passos, Camila Sanches Manca, Isabela Laurencio Schiavoni, Andreza Correa Teixeira, Ana de Lourdes Candolo Martinelli, Paula Garcia Chiarello. Hand grip strength and adductor pollicis muscle thickness in patients on palliative care for hepatocellular carcinoma. Clinical Nutrition Experimental 2018; 22: 30 doi: 10.1016/j.yclnex.2018.06.003
|
| 33 |
T. C. Saat, S. van den Engel, W. Bijman-Lachger, S. S. Korevaar, M. J. Hoogduijn, J. N. M. IJzermans, R. W. F. de Bruin. Fate and Effect of Intravenously Infused Mesenchymal Stem Cells in a Mouse Model of Hepatic Ischemia Reperfusion Injury and Resection. Stem Cells International 2016; 2016: 1 doi: 10.1155/2016/5761487
|
| 34 |
Jian Chu, Guangyong Geng, Xiaoming Ai, Wenbo Jia, Jinyi Wang, Bin Xu, Xiangxu Kong, Lianbao Kong. LINC01291 promotes hepatocellular carcinoma development by targeting the miR‐186‐5p/OXSR1 axis. The Journal of Gene Medicine 2022; 24(2) doi: 10.1002/jgm.3394
|
| 35 |
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma. American Society of Clinical Oncology Educational Book 2018; (38): 262 doi: 10.1200/EDBK_200939
|
| 36 |
Danijel Galun, Aleksandar Bogdanovic, Marko Zivanovic, Marinko Zuvela. Short- and Long-Term Outcomes After Hepatectomy in Elderly Patients with Hepatocellular Carcinoma: An Analysis of 229 Cases from a Developing Country. Journal of Hepatocellular Carcinoma 2021; : 155 doi: 10.2147/JHC.S297296
|
| 37 |
Bo Li, Boan Li, Tongsheng Guo, Zhiqiang Sun, Xiaohan Li, Xiaoxi Li, Han Wang, Weijiao Chen, Peng Chen, Mengran Qiao, Lifang Xia, Yuanli Mao. Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant Liver Tumors. Medical Science Monitor 2017; 23: 1636 doi: 10.12659/MSM.901064
|
| 38 |
Céline van de Braak, François E. J. A. Willemssen, Rob A. de Man, Aad van der Lugt, Carin A. Uyl-de Groot, Daniel Bos, Roy S. Dwarkasing. Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study. European Radiology Experimental 2024; 8(1) doi: 10.1186/s41747-024-00432-6
|
| 39 |
Qian Zhu, Bo Yuan, Guo-Liang Qiao, Jian-Jun Yan, Yun Li, Rui Duan, Yi-Qun Yan. Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients. Clinics and Research in Hepatology and Gastroenterology 2016; 40(4): 418 doi: 10.1016/j.clinre.2015.12.007
|
| 40 |
Alireza Rezaee, Rathan M. Subramaniam, Markus Raderer, Werner Langsteger, Mohsen Beheshti. PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging. 2018; : 127 doi: 10.1016/B978-0-323-48567-8.00007-9
|
| 41 |
Fuyou Zhang, Jianfa Li, Huizhong Xiao, Yifan Zou, Yuchen Liu, Weiren Huang. AFAP1‐AS1: A novel oncogenic long non‐coding RNA in human cancers. Cell Proliferation 2018; 51(1) doi: 10.1111/cpr.12397
|
| 42 |
He Ren, Chao An, Wanxi Fu, Jingyan Wu, Wenhuan Yao, Jie Yu, Ping Liang. Prediction of local tumor progression after microwave ablation for early-stage hepatocellular carcinoma with machine learning. Journal of Cancer Research and Therapeutics 2023; 19(4): 978 doi: 10.4103/jcrt.jcrt_319_23
|
| 43 |
Zeng-Fa Gao, Yong-Na Wu, Zhong-Tian Bai, Lei Zhang, Qi Zhou, Xun Li. Tumor-suppressive role of HACE1 in hepatocellular carcinoma and its clinical significance. Oncology Reports 2016; 36(6): 3427 doi: 10.3892/or.2016.5205
|
| 44 |
Liumei Luo, Li Li, Min Guo, Xi Chen, Yuzhu Lin, Dingyin Wu. Genetic variation in NRG 1 gene and risk of post‐traumatic stress disorders in patients with hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 2020; 34(5) doi: 10.1002/jcla.23187
|
| 45 |
Francesco Paolo Russo, Angela Imondi, Erica Nicola Lynch, Fabio Farinati. When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review. Digestive and Liver Disease 2018; 50(7): 640 doi: 10.1016/j.dld.2018.03.014
|
| 46 |
Danijel Galun, Dragana Mijac, Aleksandar Filipovic, Aleksandar Bogdanovic, Marko Zivanovic, Dragan Masulovic. Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective. Journal of Personalized Medicine 2022; 12(2): 149 doi: 10.3390/jpm12020149
|
| 47 |
Zhiying Shao, Xin Liu, Chanjuan Peng, Liping Wang, Dong Xu. Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02401-4
|
| 48 |
Bijay Dhungel, Aparna Jayachandran, Christopher J. Layton, Jason C. Steel. Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma. Drug Delivery 2017; 24(1): 289 doi: 10.1080/10717544.2016.1247926
|
| 49 |
Anthony B. El-Khoueiry, Tim Meyer, Ann-Lii Cheng, Lorenza Rimassa, Suvajit Sen, Steven Milwee, Robin Kate Kelley, Ghassan K. Abou-Alfa. Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09453-z
|
| 50 |
Annie Zhang, Jaganathan Lakshmanan, Amirreza Motameni, Brian G. Harbrecht. MicroRNA-203 suppresses proliferation in liver cancer associated with PIK3CA, p38 MAPK, c-Jun, and GSK3 signaling. Molecular and Cellular Biochemistry 2018; 441(1-2): 89 doi: 10.1007/s11010-017-3176-9
|
| 51 |
Jennifer N. Harmon, Foad Kabinejadian, Robinson Seda, Mario L. Fabiilli, Sibu Kuruvilla, Cathleen C. Kuo, Joan M. Greve, J. Brian Fowlkes, Joseph L. Bull. Minimally invasive gas embolization using acoustic droplet vaporization in a rodent model of hepatocellular carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-47309-y
|
| 52 |
Vivian C. Tuei, Geoffrey K. Maiyoh, Fidelis T. Ndombera. The role of infections in the causation of cancer in Kenya. Cancer Causes & Control 2022; 33(12): 1391 doi: 10.1007/s10552-022-01625-3
|
| 53 |
Nikolaos Galanakis, Elias Kehagias, Nikolas Matthaiou, Dimitrios Samonakis, Dimitrios Tsetis. Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review. Hepatic Oncology 2018; 5(2): HEP07 doi: 10.2217/hep-2018-0001
|
| 54 |
Swetha Kambhampati, Kelly E. Bauer, Paige M. Bracci, Bridget P. Keenan, Spencer C. Behr, John D. Gordan, Robin K. Kelley. Nivolumab in patients with advanced hepatocellular carcinoma and Child‐Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series. Cancer 2019; 125(18): 3234 doi: 10.1002/cncr.32206
|
| 55 |
Haoran Xu, Yongjia Tang, Yue Zhao, Fang Wang, Xin Gao, Dawei Deng, Yueqing Gu. SPECT Imaging of Hepatocellular Carcinoma Detection by the GPC3 Receptor. Molecular Pharmaceutics 2021; 18(5): 2082 doi: 10.1021/acs.molpharmaceut.1c00060
|
| 56 |
Small Nucleolar RNA Host Gene 18 Acts as a Tumor Suppressor and a Diagnostic Indicator in Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2018; 17: 153303381879449 doi: 10.1177/1533033818794494
|
| 57 |
Bijay Dhungel, Slawomir Andrzejewski, Aparna Jayachandran, Ritu Shrestha, Charmaine A. Ramlogan-Steel, Christopher J. Layton, Jason C. Steel. Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinoma. Gene Therapy 2018; 25(2): 115 doi: 10.1038/s41434-018-0002-2
|
| 58 |
Honghong Liu, Ping Zhao, Xueyuan Jin, Yanling Zhao, Yongqian Chen, Tao Yan, Jianjun Wang, Liang Wu, Yongqiang Sun. A 9‑lncRNA risk score system for predicting the prognosis of patients with hepatitis B virus‑positive hepatocellular carcinoma. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10262
|
| 59 |
Raj Mohan Paspulati, Amit Gupta. PET/MR Imaging in Cancers of the Gastrointestinal Tract. PET Clinics 2016; 11(4): 403 doi: 10.1016/j.cpet.2016.05.004
|
| 60 |
Soojin Kim, Kyung Hyun Kim, Beom Kyung Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim, Seung Up Kim. Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2021; 36(5): 1317 doi: 10.1111/jgh.15355
|
| 61 |
Lior Charach, Lior Zusmanovitch, Gideon Charach. Hepatocellular Carcinoma. Part 1: Epidemiology, Risk Factors, Pathogenesis, and Pathology. EMJ Hepatology 2017; : 75 doi: 10.33590/emjhepatol/10312421
|
| 62 |
Si Ying Tang, Ying Xu, Cong Cong Jiao, Meng Hui Jiang, Nan Kong, Hao Ding, Lian Hua Cui, Jin-Mei Piao. Clinical significance of cylindromatosis expression in primary hepatocellular carcinoma. Arab Journal of Gastroenterology 2023; 24(1): 58 doi: 10.1016/j.ajg.2022.11.001
|
| 63 |
Wei Jing, Shanshan Gao, Man Zhu, Ping Luo, Xuan Jing, Hongyan Chai, Jiancheng Tu. Potential diagnostic value of lncRNA SPRY4-IT1 in hepatocellular carcinoma. Oncology Reports 2016; 36(2): 1085 doi: 10.3892/or.2016.4859
|
| 64 |
Chunye Zhang, Ming Yang, Aaron C. Ericsson. Antimicrobial Peptides: Potential Application in Liver Cancer. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01257
|
| 65 |
Honghua Yan, Kyung Hee Jung, Juyoung Kim, Marufa Rumman, Myung Sook Oh, Soon-Sun Hong. Artemisia capillaris extract AC68 induces apoptosis of hepatocellular carcinoma by blocking the PI3K/AKT pathway. Biomedicine & Pharmacotherapy 2018; 98: 134 doi: 10.1016/j.biopha.2017.12.043
|
| 66 |
Arnetta N.L. Lalisang, Nathaniel J. Zacharia, Indah Jamtani, Vania M.G. Marbun, Wifanto Saditya Jeo, Toar Jean Maurice Lalisang. Pedunculated hepatocellular carcinoma masquerading as a giant GIST: A case report. International Journal of Surgery Case Reports 2023; 105: 108102 doi: 10.1016/j.ijscr.2023.108102
|
| 67 |
Rui-Qing Zong, Hong-Yan Zhang, Xiao-Ying Li, Yi-ran Li, Ying Chen, Ying-Kun Xu. Overexpressed Histocompatibility Minor 13 was Associated with Liver Hepatocellular Carcinoma Progression and Prognosis. Genetics Research 2022; 2022: 1 doi: 10.1155/2022/7067743
|
| 68 |
Bee Ling Tan, Mohd Esa Norhaizan. Anticancer plants: Properties and Application. 2018; : 91 doi: 10.1007/978-981-10-8548-2_5
|
| 69 |
Rahul Agarwal, Yuan Cao, Klaus Hoffmeier, Nicolas Krezdorn, Lukas Jost, Alejandro Rodriguez Meisel, Ruth Jüngling, Francesco Dituri, Serena Mancarella, Björn Rotter, Peter Winter, Gianluigi Giannelli. Precision medicine for hepatocelluar carcinoma using molecular pattern diagnostics: results from a preclinical pilot study. Cell Death & Disease 2017; 8(6): e2867 doi: 10.1038/cddis.2017.229
|
| 70 |
Lushan Xiao, Zixiao Zhou, Wenwen Li, Jie Peng, Qingcan Sun, Hongbo Zhu, Yang Song, Jin-Lin Hou, Jingyuan Sun, Hui-Chuan Cao, Dong Zhongyi, Dehua Wu, Li Liu. Chromobox homolog 8 (CBX8) Interacts with Y-Box binding protein 1 (YBX1) to promote cellular proliferation in hepatocellular carcinoma cells. Aging 2019; 11(17): 7123 doi: 10.18632/aging.102241
|
| 71 |
Bijay Dhungel, Charmaine A. Ramlogan-Steel, Jason C. Steel. Synergistic and independent action of endogenous microRNAs 122a and 199a for post-transcriptional liver detargeting of gene vectors. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33801-4
|
| 72 |
Hsuan Yeh, Chun-Cheng Chiang, Tzung-Hai Yen. Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges. World Journal of Gastroenterology 2021; 27(26): 4104-4142 doi: 10.3748/wjg.v27.i26.4104
|
| 73 |
Zhijun Yu, Yinyin Li, Tao Han, Zhaozhe Liu. Demethylation of the HACE1 gene promoter inhibits the proliferation of human liver cancer cells. Oncology Letters 2019; doi: 10.3892/ol.2019.10139
|
| 74 |
Jianfa Li, Yincong Chen, Zhicong Chen, Anbang He, Haibiao Xie, Qiaoxiao Zhang, Zhiming Cai, Yuchen Liu, Weiren Huang. SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers. Tumor Biology 2017; 39(6): 101042831771140 doi: 10.1177/1010428317711406
|
| 75 |
Leva Gorji, Zachary J. Brown, Timothy M. Pawlik. Mutational Landscape and Precision Medicine in Hepatocellular Carcinoma. Cancers 2023; 15(17): 4221 doi: 10.3390/cancers15174221
|
| 76 |
Reena Thakur, Chander Raman Suri, Indu Pal Kaur, Praveen Rishi. Peptides as Diagnostic, Therapeutic, and Theranostic Tools: Progress and Future Challenges. Critical Reviews™ in Therapeutic Drug Carrier Systems 2023; 40(1): 49 doi: 10.1615/CritRevTherDrugCarrierSyst.2022040322
|
| 77 |
Huijie Jia, Tiesuo Zhao, Di Zou, Xiaolong Jia, Ji Gao, Xiangfeng Song. Therapeutic Injection of a C-Type CpG ODN Induced an Antitumor Immune Response in C57/BL6 Mice of Orthotopically Transplanted Hepatocellular Carcinoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2016; 23(6): 321 doi: 10.3727/096504016X14570992647041
|
| 78 |
Huizhong Xiao, Fuyou Zhang, Yifan Zou, Jianfa Li, Yuchen Liu, Weiren Huang. The Function and Mechanism of Long Non-coding RNA-ATB in Cancers. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.00321
|
| 79 |
Sergio Fuentes-Hernández, Brisa Rodope Alarcón-Sánchez, Dafne Guerrero-Escalera, Alexia Viridiana Montes-Aparicio, María Paulette Castro-Gil, Osiris Germán Idelfonso-García, Sandra Rosas-Madrigal, Diana Ivette Aparicio-Bautista, José Luis Pérez-Hernández, Karina Reyes-Gordillo, M. Raj Lakshman, Verónica Rocío Vásquez-Garzón, Rafael Baltiérrez-Hoyos, Ma. de Lourdes López-González, Adolfo Sierra-Santoyo, Saúl Villa-Treviño, Julio Isael Pérez-Carreón, Jaime Arellanes-Robledo. Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice. Toxicology and Applied Pharmacology 2019; 378: 114611 doi: 10.1016/j.taap.2019.114611
|
| 80 |
Kibo Nam, Maria Stanczak, Flemming Forsberg, Colette M. Shaw, John R. Eisenbrey. Evaluation of hepatocellular carcinoma transarterial chemoembolization using 3D contrast enhanced ultrasound time-intensity curve analysis. 2017 IEEE International Ultrasonics Symposium (IUS) 2017; : 1 doi: 10.1109/ULTSYM.2017.8092790
|
| 81 |
Néstor Prieto-Domínguez, Carolina Méndez-Blanco, Sara Carbajo-Pescador, Flavia Fondevila, Andrés García-Palomo, Javier González-Gallego, José L. Mauriz. Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy. Oncotarget 2017; 8(53): 91402 doi: 10.18632/oncotarget.20592
|
| 82 |
Nuray Üremiş, Muhammed Mehdi Üremiş, Yılmaz Çiğremiş, Emir Tosun, Ahmet Baysar, Yusuf Türköz.
Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of
JAK
/
STAT3
,
MAPK
/
ERK
, and
AKT
/
mTOR
signaling pathways in
HepG2
cell line
. Journal of Food Biochemistry 2022; 46(10) doi: 10.1111/jfbc.14333
|
| 83 |
Shiwen Xi, Yong-Guang Yang, Jian Suo, Tianmeng Sun. Research Progress on Gene Editing Based on Nano-Drug Delivery Vectors for Tumor Therapy. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.873369
|
| 84 |
Mingjia Gu, Fang Yin, Yuening Qin, Yali Tian, Xinjie Xiu, Hanjing Shen, Jiebin Zhu. Synergistic antitumor efficacy of PD-1-conjugated PTX- and ZSQ-loaded nanoliposomes against multidrug-resistant liver cancers. Drug Delivery and Translational Research 2022; 12(10): 2550 doi: 10.1007/s13346-021-01106-1
|
| 85 |
Li Yin, Zhihui Cai, Baoan Zhu, Cunshuan Xu. Identification of Key Pathways and Genes in the Dynamic Progression of HCC Based on WGCNA. Genes 2018; 9(2): 92 doi: 10.3390/genes9020092
|
| 86 |
Katherine E Redd Bowman, Phong Lu, Erica R Vander Mause, Carol S Lim. Advances in delivery vectors for gene therapy in liver cancer. Therapeutic Delivery 2020; 11(1): 833 doi: 10.4155/tde-2019-0076
|
| 87 |
Haijun Wang, Maria Carmenza Mejia, Sandra J. Gonzalez, Roger J. Zoorob, Weiwen Chai, Xianglin L. Du. Cancer incidence and survival trends among infants in the United States from 1975 to 2014. Pediatric Blood & Cancer 2021; 68(4) doi: 10.1002/pbc.28917
|
| 88 |
佳骏 芦. Application of Serum Biomarkers in Early Diagnosis and Prognosis of Hepatocellular Carcinoma. Advances in Clinical Medicine 2022; 12(06): 5446 doi: 10.12677/ACM.2022.126789
|
| 89 |
Fei Chen, Yuhong Li, Yanhong Feng, Xiuli He, Liang Wang. Evaluation of Antimetastatic Effect of lncRNA-ATB siRNA Delivered Using Ultrasound-Targeted Microbubble Destruction. DNA and Cell Biology 2016; 35(8): 393 doi: 10.1089/dna.2016.3254
|
| 90 |
Dongqiang Song, Beili Xu, Dongmin Shi, Shuyu Li, Yu Cai. S100A6 promotes proliferation and migration of HepG2 cells via increased
ubiquitin-dependent degradation of p53. Open Medicine 2020; 15(1): 317 doi: 10.1515/med-2020-0101
|
| 91 |
Olfat Al-Harazi, Ibrahim H. Kaya, Maha Al-Eid, Lina Alfantoukh, Ali Saeed Al Zahrani, Mohammed Al Sebayel, Namik Kaya, Dilek Colak. Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic and Network Analyses. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.710049
|
| 92 |
Congren Wang, Shaoying Ke, Mingzhu Li, Conglin Lin, Xiaoyu Liu, Qunxiong Pan. Downregulation of LncRNA GAS5 promotes liver cancer proliferation and drug resistance by decreasing PTEN expression. Molecular Genetics and Genomics 2020; 295(1): 251 doi: 10.1007/s00438-019-01620-5
|
| 93 |
Hamidreza Khodajou-Masouleh, Masoud Mashhadi Akbar Boojar, Sarah Khavari-Nejad, Gilda Karimi. Induction of apoptosis by Oleracein A and Oleracein B in HepG2 cancerous cells is mediated by ceramide generation, caspase-9/caspase-3 pathway activation, and oxidative damage. Pharmacological Research - Modern Chinese Medicine 2022; 2: 100047 doi: 10.1016/j.prmcm.2022.100047
|
| 94 |
Dong Sun, Jinghui Lu, Chunxiao Hu, Qiangbo Zhang, Xiangdong Wang, Zongli Zhang, Sanyuan Hu. Prognostic role of miR‑760 in hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9546
|
| 95 |
Satoshi Fuji, Shugo Suzuki, Aya Naiki-Ito, Hiroyuki Kato, Masashi Hayakawa, Yoriko Yamashita, Toshiya Kuno, Satoru Takahashi. The NADPH Oxidase Inhibitor Apocynin Suppresses Preneoplastic Liver Foci of Rats. Toxicologic Pathology 2017; 45(4): 544 doi: 10.1177/0192623317710013
|
| 96 |
Ayesha Khalid, Tabinda Hussain, Sobia Manzoor, Muhammad Saalim, Saba Khaliq. PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma. Tumor Biology 2017; 39(6): 101042831770575 doi: 10.1177/1010428317705754
|
| 97 |
Xuejing Zou, Jiyun Liang, Jingyuan Sun, Xiaoyun Hu, Ling Lei, Dehua Wu, Li Liu. Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway. Journal of Pharmacological Sciences 2016; 131(4): 233 doi: 10.1016/j.jphs.2016.04.017
|
| 98 |
Chuangjie Mao, Huitao Wen, Yiqian Zhang, Ge Yu, Qui Ge. ciRS-7 Enhances the Progression of Hepatocellular Carcinoma through miR-944/NOX4 Pathway. Critical Reviews in Eukaryotic Gene Expression 2022; 32(7): 11 doi: 10.1615/CritRevEukaryotGeneExpr.2022039225
|
| 99 |
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?. World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
|
| 100 |
Tao Su, Teng Wang, Nasha Zhang, Yue Shen, Wenwen Li, Huaixin Xing, Ming Yang. Long non-coding RNAs in gastrointestinal cancers: Implications for protein phosphorylation. Biochemical Pharmacology 2022; 197: 114907 doi: 10.1016/j.bcp.2022.114907
|
| 101 |
Yunhao Wang, Qingfu Zhao, Binyu Zhao, Youshi Zheng, Qiuyu Zhuang, Naishun Liao, Peiyuan Wang, Zhixiong Cai, Da Zhang, Yongyi Zeng, Xiaolong Liu. Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency. Advanced Science 2022; 9(11) doi: 10.1002/advs.202105631
|
| 102 |
Lindsay A. Sobotka, Alice Hinton, Lanla F. Conteh. Insurance status impacts treatment for hepatocellular carcinoma. Annals of Hepatology 2019; 18(3): 461 doi: 10.1016/j.aohep.2018.10.001
|
| 103 |
Min Ding, Ying Wang, Jiachang Chi, Tao Wang, Xiaoyin Tang, Dan Cui, Qijun Qian, Bo Zhai, Beicheng Sun. Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 Patients. PLOS ONE 2016; 11(12): e0168798 doi: 10.1371/journal.pone.0168798
|
| 104 |
Mahboobeh Akbarizare, Hamideh Ofoghi, Mahnaz Hadizadeh, Nasrin Moazami. In vitro assessment of the cytotoxic effects of secondary metabolites from Spirulina platensis on hepatocellular carcinoma. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-0018-3
|
| 105 |
Mi Wen, Gao Zi Sen, Hu Pei, Di Xin. Uncovering the relationship between hepatocellular carcinoma and compounds belonging to Simaroubaceae using a network pharmacology approach and molecular docking techniques. Computational Toxicology 2021; 17: 100152 doi: 10.1016/j.comtox.2020.100152
|
| 106 |
Yang Gu, Jun Li, Deliang Guo, Baiyang Chen, Pengpeng Liu, Yusha Xiao, Kang Yang, Zhisu Liu, Quanyan Liu. Identification of 13 Key Genes Correlated With Progression and Prognosis in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00153
|